However, unlike the patients on general surgery, only 43% of neurosurgery patients, 49% of orthopedics patients and 48% of urology patients whose hyperglycemia frequencies were in the highest tertile received basal-bolus insulin therapy. This evidence concerns the gene INS and Hyperglycemia.